GB:SCLP Stock Latest News
Company AnnouncementsScancell clears share consolidation as it readies AIM trading and deal push3w ago
Company AnnouncementsScancell Issues Shares Ahead of Consolidation and Publishes 2026 Annual Report4w ago
Company AnnouncementsScancell Bolsters Cancer Immunotherapy Push With Nasdaq Move and $75m Funding1M ago
Company AnnouncementsScancell Sets Vote on Neuphoria Merger and 10-for-1 Share Consolidation1M ago
Company AnnouncementsScancell Secures Up to US$25m BlackRock Debt to Drive iSCIB1+ Phase 31M agoCompany AnnouncementsScancell’s Phase 3 Melanoma Vaccine Trial Moves Toward Launch, Raising Long-Term Upside Questions2M agoSCLP
Company AnnouncementsScancell to Highlight Late-Stage Cancer Immunotherapy and U.S. Deal Plans at Wainwright Conference2M ago
Company AnnouncementsScancell Wins UK Green Light for Global Phase 3 Melanoma Trial of iSCIB1+2M ago
Company AnnouncementsScancell Extends CSO Share Option Exercise Period3M ago
Company AnnouncementsScancell Raises £15.7m After Oversubscribed Retail Offer and UK Placing3M ago- Company AnnouncementsScancell and Neuphoria in all-share merger backed by $89m financing for melanoma trial3M ago
Company AnnouncementsScancell upsizes oversubscribed £13m UK placing to extend funding runway3M agoCompany AnnouncementsScancell launches discounted UK share placing to fund Phase 3 melanoma trial3M ago
Company AnnouncementsScancell launches retail offer and placing to extend cash runway into 20273M ago
Company AnnouncementsScancell to Merge with Neuphoria and Secure Up to $89m for Phase 3 Melanoma Trial3M ago
Company AnnouncementsScancell in advanced talks on Neuphoria reverse merger and Nasdaq listing4M ago- Company AnnouncementsScancell Wins FDA Fast Track for Melanoma Vaccine as Phase 2 Data Strengthen6M ago
- Company AnnouncementsScancell Taps Veteran Biotech Financier as Interim CFO Amid iSCIB1+ Push7M ago
Company AnnouncementsScancell Holdings Charts Risky but Promising Phase III Path9M agoCompany AnnouncementsScancell Secures FDA Green Light for Phase 3 Melanoma Trial as Pipeline and Cash Runway Advance9M ago
Company AnnouncementsScancell Wins FDA Nod for Phase 3 Melanoma Trial of iSCIB1+ After Strong Phase 2 Data9M ago
